USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Inventories

Inventories

12 Months Ended

Jan. 03, 2015

NOTE C – INVENTORIES


Inventories consist of the following:
	December 28,	January 3,
	2013	2015

Raw materials	$ 13,824	$ 15,127
Work in progress	8,147	7,545
Finished goods	25,271	22,576

	$ 47,242	$ 45,248

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References + Details